Leading up to the recent FDA approval, Gary Wörtz, MD, invites Bill Trattler, MD, to talk about his experience with corneal collagen cross-linking and how it is becoming the new standard of care. Dr. Trattler explains the significance of having this treatment option for patients with ectasia and keratoconus and sheds light on the importance of early intervention.